Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06312267 · ClinicalTrials.gov registry record · NA

Reducing Wound Infections Using Bioelectric Wound Dressings

A NA study of Surgical Site Infection, sponsored by AdventHealth.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06312267: Recruiting NA study of Surgical Site Infection, sponsored by AdventHealth.

NCT06312267 is a NA study of Surgical Site Infection that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 20 participants, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06312267, a NA study of Surgical Site Infection, is actively recruiting participants, sponsored by AdventHealth.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on the pre-operative wound site and post operatively and compared it outcomes to the standard of care chlorhexidine skin preparation.

Conditions Studied

Interventions

  • DEVICE Bioelectric dressing

Study Locations (1)

Florida

  • AdventHealth Celebration - Kissimmee

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-04
Est. Completion 2025-03-01
Phase NA
AdventHealth

95 total trials

What NCT06312267 shows while recruiting

NCT06312267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 568-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 1 intervention - of which Bioelectric dressing is the first listed.

NCT06312267 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06312267 about?

NCT06312267 is a clinical study titled "Reducing Wound Infections Using Bioelectric Wound Dressings". The purpose of this study is to compare the outcomes of using Bioelectric wound dressing on the pre-operative wound site and post operatively and compared it outcomes to the standard of care chlorhexidine skin preparation.

What is the current status of trial NCT06312267?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-04. Estimated completion is 2025-03-01.

What conditions does trial NCT06312267 study?

This clinical trial studies the following conditions: Surgical Site Infection.

What interventions are being tested in trial NCT06312267?

The interventions under investigation include: Bioelectric dressing (DEVICE).

Who is sponsoring clinical trial NCT06312267?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06312267 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Site Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06312267's enrollment target sits among peer trials

20 25th of 25 higher than 1 of 25 other Surgical Site Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06312267, the US trial registry maintained by the National Library of Medicine. NCT06312267 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.